Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Group |
Environmental Condition |
Log2FC |
|
Tac1p
|
C3_04890W_A
|
PubMed
Coste AT et al., Eukaryotic cell, 2004 Dec;3(6):1639-52Coste AT et al., Eukaryotic cell, 2004 Dec;3(6):1639-52 |
Direct |
EMSA |
N/A |
SC5314 |
Unstressed log-phase growth (control) |
Control |
N/A |
| Indirect |
Northern blot - wt vs TF mutant |
Positive |
SC5314 |
Stress |
Fluphenazine |
N/A |
| Indirect |
lacZ - wt vs TF mutant |
Positive |
SC5314 |
Stress |
Fluphenazine |
N/A |
| Indirect |
Microarray analysis - WT vs TF Deletion |
Positive |
CAF2-1 |
Stress |
Each strain was pregrown overnight in 5 ml of YEPD with constant agitation at 30°C. Strains were exposed for 20 min to 10 μg of fluphenazine. |
N/A |
PubMed
Coste A et al., Eukaryotic cell, 2007 Oct;6(10):1889-904Coste A et al., Eukaryotic cell, 2007 Oct;6(10):1889-904 |
Indirect |
Western blot - wt vs TF mutant |
Positive |
SC5314 |
Stress |
Fluphenazine |
N/A |
PubMed
Znaidi S et al., Molecular microbiology, 2007 Oct;66(2):440-52Znaidi S et al., Molecular microbiology, 2007 Oct;66(2):440-52 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
SC5314 |
Unstressed log-phase growth (control) |
Control |
N/A |
PubMed
Liu TT et al., Eukaryotic cell, 2007 Nov;6(11):2122-38Liu TT et al., Eukaryotic cell, 2007 Nov;6(11):2122-38 |
Direct |
Chip-on-chip |
N/A |
SC5314 |
Unstressed log-phase growth (control) |
Control |
N/A |
PubMed
MacCallum DM et al., Antimicrobial agents and chemotherapy, 2010 Apr;54(4):1476-83MacCallum DM et al., Antimicrobial agents and chemotherapy, 2010 Apr;54(4):1476-83 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
SC5314 |
Unstressed log-phase growth (control) |
Control |
N/A |
PubMed
Sasse C et al., PloS one, 2011;6(9):e25623Sasse C et al., PloS one, 2011;6(9):e25623 |
Indirect |
Western blot - wt vs TF mutant |
Positive |
SC5314 |
Stress |
Fluphenazine |
N/A |
PubMed
Lohberger A et al., Eukaryotic cell, 2014 Jan;13(1):127-42Lohberger A et al., Eukaryotic cell, 2014 Jan;13(1):127-42 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SC5314 |
Unstressed log-phase growth (control) |
Control |
N/A |
| Indirect |
Western blot - wt vs TF mutant |
Positive |
SC5314 |
Stress |
Fluphenazine |
N/A |
PubMed
Liu Z et al., Antimicrobial agents and chemotherapy, 2017 Nov;61(11):Liu Z et al., Antimicrobial agents and chemotherapy, 2017 Nov;61(11): |
Direct |
ChIP |
N/A |
SC5314 |
Unstressed log-phase growth (control) |
YPD |
N/A |
| Direct |
ChIP |
N/A |
SC5314 |
Stress |
10 mg/L fluphenazine during 15 min |
N/A |
| Direct |
ChIP |
Positive |
SC5314 |
Stress |
Fluphenazinee stress (10 microg/mL for 15 min) |
N/A |
| Direct |
RT-PCR - wt vs mutant promoter sequence |
Positive |
SC5314 |
Stress |
10 mg/L fluphenazine |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SC5314 |
Unstressed log-phase growth (control) |
YPD |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SC5314 |
Stress |
20 mg/L fluphenazine during 30 min |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SC5314 |
Stress |
Fluphenazine stress |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SC5314 |
Unstressed log-phase growth (control) |
Control, YPD, 30.C |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SC5314 |
Stress |
Fluphenazinee stress (20 microg/mL for 30 min) |
N/A |
| Indirect |
RT-PCR - wt vs TF overexpression |
Positive |
SC5314 |
Unstressed log-phase growth (control) |
YPD |
N/A |
PubMed
Liu Z et al., Antimicrobial agents and chemotherapy, 2018 Nov;62(11):Liu Z et al., Antimicrobial agents and chemotherapy, 2018 Nov;62(11): |
Direct |
ChIP |
N/A |
SN152 |
Unstressed log-phase growth (control) |
Control |
N/A |
| Direct |
ChIP |
N/A |
SN152 |
Stress |
Farnesol stess (50 microM) |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SN152 |
Stress |
1-Dodecanol stress (50 microM) |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SN152 |
Stress |
Farnesol stess (50 microM) |
N/A |
| Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SN152 |
Stress |
Fluphenazinee stress (25 microM) |
N/A |
PubMed
Liu JY et al., Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020 Dec;51(4):1553-1561Liu JY et al., Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020 Dec;51(4):1553-1561 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SN152 |
Unstressed log-phase growth (control) |
Control, YPD, 30.C |
N/A |
| Indirect |
Western blot - wt vs TF mutant |
Positive |
SN152 |
Unstressed log-phase growth (control) |
Control, YPD, 30.C |
N/A |
| Indirect |
Western blot - wt vs TF mutant |
Positive |
SN152 |
Stress |
Fluphenazine stress (10 mg/L for 6h) |
N/A |
PubMed
Lim WJ et al., Microbiology (Reading, England), 2025 Sep;171(9):Lim WJ et al., Microbiology (Reading, England), 2025 Sep;171(9): |
Indirect |
RNA-seq analysis - TF GOF vs WT |
Positive |
CC16 |
Unstressed log-phase growth (control) |
Grown overnight in YEPD broth in a shaking incubator at 200 rpm, cultures inoculated to an OD600 = 0.1 and incubated at 37 °C with 200 rpm shaking until an OD600=0.8. Transcription factor gene gain-of-function in a Δtlo strain. |
4.23921811643307 |